XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Millions
Total
Serial Preferred Shares, No Par Value
Common Shares, $1.00 Par Value
Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Balance, Beginning of period at Dec. 31, 2023   $ 494 $ 585 $ 2,013 $ 18,801 $ (1,616)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Redemption of Serial Preferred Shares, Series B [1]   (494)        
Treasury shares purchased     (1) (2) (131)  
Net restricted equity awards issued/vested     2 (2)    
Amortization of equity-based compensation       86    
Reinvested dividends on restricted stock units       1 (1)  
Net income $ 6,124       6,124  
Cash dividends declared on common shares ($0.10, $0.10, $0.30, and $0.30 per share) [1]         (176)  
Cash dividends declared on Serial Preferred Shares, Series B ($0, $0, $0, and $15.688377 per share) [1]         (8)  
Other, net         23  
Other comprehensive income (loss) 1,461         1,461
Balance, End of period at Sep. 30, 2024 27,159 0 586 2,096 24,632 (155)
Balance, Beginning of period at Jun. 30, 2024   0 586 2,060 22,410 (1,716)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Redemption of Serial Preferred Shares, Series B [1]   0        
Treasury shares purchased     (1) (1) (84)  
Net restricted equity awards issued/vested     1 (1)    
Amortization of equity-based compensation       38    
Reinvested dividends on restricted stock units       0 0  
Net income 2,334       2,334  
Cash dividends declared on common shares ($0.10, $0.10, $0.30, and $0.30 per share) [1]         (59)  
Cash dividends declared on Serial Preferred Shares, Series B ($0, $0, $0, and $15.688377 per share) [1]         0  
Other, net         31  
Other comprehensive income (loss) 1,561         1,561
Balance, End of period at Sep. 30, 2024 27,159 0 586 2,096 24,632 (155)
Balance, Beginning of period at Dec. 31, 2024 25,591 0 586 2,145 24,283 (1,423)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Redemption of Serial Preferred Shares, Series B [1]   0        
Treasury shares purchased     (1) (1) (105)  
Net restricted equity awards issued/vested     1 (1)    
Amortization of equity-based compensation       90    
Reinvested dividends on restricted stock units       0 0  
Net income 8,357       8,357  
Cash dividends declared on common shares ($0.10, $0.10, $0.30, and $0.30 per share) [1]         (176)  
Cash dividends declared on Serial Preferred Shares, Series B ($0, $0, $0, and $15.688377 per share) [1]         0  
Other, net         78  
Other comprehensive income (loss) 1,612         1,612
Balance, End of period at Sep. 30, 2025 35,445 0 586 2,233 32,437 189
Balance, Beginning of period at Jun. 30, 2025   0 586 2,192 29,921 (95)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Redemption of Serial Preferred Shares, Series B [1]   0        
Treasury shares purchased     (1) 0 (39)  
Net restricted equity awards issued/vested     1 (1)    
Amortization of equity-based compensation       42    
Reinvested dividends on restricted stock units       0 0  
Net income 2,615       2,615  
Cash dividends declared on common shares ($0.10, $0.10, $0.30, and $0.30 per share) [1]         (59)  
Cash dividends declared on Serial Preferred Shares, Series B ($0, $0, $0, and $15.688377 per share) [1]         0  
Other, net         (1)  
Other comprehensive income (loss) 284         284
Balance, End of period at Sep. 30, 2025 $ 35,445 $ 0 $ 586 $ 2,233 $ 32,437 $ 189
[1] See Note 9 – Dividends for further discussion.